These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 26501236)

  • 1. Outcome Preferences in Patients With Noninfectious Uveitis: Results of a Best-Worst Scaling Study.
    Yu T; Holbrook JT; Thorne JE; Flynn TN; Van Natta ML; Puhan MA
    Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6864-72. PubMed ID: 26501236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness of Vision-Specific and General Quality of Life Metrics to Ocular and Systemic Events in Patients with Uveitis.
    Sugar EA; Burke AE; Venugopal V; Thorne JE; Holbrook JT;
    Ophthalmology; 2020 Dec; 127(12):1710-1718. PubMed ID: 32717341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis.
    ; Kempen JH; Altaweel MM; Holbrook JT; Sugar EA; Thorne JE; Jabs DA
    JAMA; 2017 May; 317(19):1993-2005. PubMed ID: 28477440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time Trade-off Utility Values in Noninfectious Uveitis.
    Niemeyer KM; Gonzales JA; Doan T; Browne EN; Rao MM; Acharya NR
    Am J Ophthalmol; 2019 Dec; 208():47-55. PubMed ID: 31201795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of elevated intraocular pressure and glaucoma in patients with uveitis: results of the multicenter uveitis steroid treatment trial.
    Friedman DS; Holbrook JT; Ansari H; Alexander J; Burke A; Reed SB; Katz J; Thorne JE; Lightman SL; Kempen JH;
    Ophthalmology; 2013 Aug; 120(8):1571-9. PubMed ID: 23601801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health- and Vision-Related Quality of Life in a Randomized Controlled Trial Comparing Methotrexate and Mycophenolate Mofetil for Uveitis.
    Kelly NK; Chattopadhyay A; Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Cugley D; Lim LL; Suhler EB; Al-Dhibi HA; Ebert CD; Berlinberg EJ; Porco TC; Acharya NR;
    Ophthalmology; 2021 Sep; 128(9):1337-1345. PubMed ID: 33675850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of Life in Patients with Noninfectious Uveitis Treated with or without Systemic Anti-inflammatory Therapy.
    Gui W; Dombrow M; Marcus I; Stowe MH; Tessier-Sherman B; Yang E; Huang JJ
    Ocul Immunol Inflamm; 2015 Apr; 23(2):135-43. PubMed ID: 24867459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normative comparison of patient-reported outcomes in patients with noninfectious uveitis.
    Naik RK; Rentz AM; Foster CS; Lightman S; Belfort R; Lowder C; Whitcup SM; Kowalski JW; Revicki DA
    JAMA Ophthalmol; 2013 Feb; 131(2):219-25. PubMed ID: 23411886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Corticosteroid-Sparing Treatment With Mycophenolate Mofetil vs Methotrexate on Inflammation in Patients With Uveitis: A Randomized Clinical Trial.
    Rathinam SR; Gonzales JA; Thundikandy R; Kanakath A; Murugan SB; Vedhanayaki R; Lim LL; Suhler EB; Al-Dhibi HA; Doan T; Keenan JD; Rao MM; Ebert CD; Nguyen HH; Kim E; Porco TC; Acharya NR;
    JAMA; 2019 Sep; 322(10):936-945. PubMed ID: 31503307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis.
    Kothari S; Foster CS; Pistilli M; Liesegang TL; Daniel E; Sen HN; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Lawrence SD; Kempen JH;
    Ophthalmology; 2015 Oct; 122(10):1987-2001. PubMed ID: 26233626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of intravenous secukinumab in noninfectious uveitis requiring steroid-sparing immunosuppressive therapy.
    Letko E; Yeh S; Foster CS; Pleyer U; Brigell M; Grosskreutz CL;
    Ophthalmology; 2015 May; 122(5):939-48. PubMed ID: 25638011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Noninfectious Uveitis and Psychological Stress.
    Berlinberg EJ; Gonzales JA; Doan T; Acharya NR
    JAMA Ophthalmol; 2019 Feb; 137(2):199-205. PubMed ID: 30520957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid implants for chronic non-infectious uveitis.
    Reddy A; Liu SH; Brady CJ; Sieving PC; Palestine AG
    Cochrane Database Syst Rev; 2023 Jan; 1(1):CD010469. PubMed ID: 36645716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Vision-Related Quality of Life for Patients with Noninfectious Uveitis Treated with Fluocinolone Acetonide Implant or Systemic Corticosteroid Therapy.
    Sugar EA; Venugopal V; Thorne JE; Frick KD; Holland GN; Wang RC; Almanzor R; Jabs DA; Holbrook JT;
    Ophthalmology; 2017 Nov; 124(11):1662-1669. PubMed ID: 28624167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adalimumab in Patients with Active Noninfectious Uveitis.
    Jaffe GJ; Dick AD; Brézin AP; Nguyen QD; Thorne JE; Kestelyn P; Barisani-Asenbauer T; Franco P; Heiligenhaus A; Scales D; Chu DS; Camez A; Kwatra NV; Song AP; Kron M; Tari S; Suhler EB
    N Engl J Med; 2016 Sep; 375(10):932-43. PubMed ID: 27602665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal Dexamethasone Implant in the Treatment of Non-infectious Uveitis.
    Hasanreisoğlu M; Özdemir HB; Özkan K; Yüksel M; Aktaş Z; Atalay HT; Özdek Ş; Gürelik G
    Turk J Ophthalmol; 2019 Oct; 49(5):250-257. PubMed ID: 31650791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of best-worst scaling to assess patient perceptions of treatments for refractory overactive bladder.
    Beusterien K; Kennelly MJ; Bridges JF; Amos K; Williams MJ; Vasavada S
    Neurourol Urodyn; 2016 Nov; 35(8):1028-1033. PubMed ID: 26370222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Systematic Review Comparing the Acceptability, Validity and Concordance of Discrete Choice Experiments and Best-Worst Scaling for Eliciting Preferences in Healthcare.
    Whitty JA; Oliveira Gonçalves AS
    Patient; 2018 Jun; 11(3):301-317. PubMed ID: 29177797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraocular methotrexate can induce extended remission in some patients in noninfectious uveitis.
    Taylor SR; Banker A; Schlaen A; Couto C; Matthe E; Joshi L; Menezo V; Nguyen E; Tomkins-Netzer O; Bar A; Morarji J; McCluskey P; Lightman S
    Retina; 2013; 33(10):2149-54. PubMed ID: 23615343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the Preferences of Patients and the General Public for Treatment Outcomes in Type 2 Diabetes Mellitus.
    Crossnohere NL; Janse S; Janssen E; Bridges JFP
    Patient; 2021 Jan; 14(1):89-100. PubMed ID: 32885395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.